Study supports pre-surgery use of GLP-1 RAs for weight reduction
Sebastian Ujică
University of Birmingham Aug 12 2025 Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of surgical complications linked to their obesity, a new study reveals. The study highlights glucagon -like peptide-1 receptor agonists (GLP-1 RAs) as a promising medication given before surgery that help control blood sugar and support weight loss - potentially improving surgical outcomes and reducing healthcare burdens associated with
din zilele anterioare